Page last updated: 2024-09-03

flag peptide and Hematologic Malignancies

flag peptide has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berahovich, R; Garcia, A; Golubovskaya, VM; Harto, H; Liu, F; Wu, L; Xu, Q; Xu, S; Zhou, H	1

Other Studies

1 other study(ies) available for flag peptide and Hematologic Malignancies

Article	Year
FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells Frontiers in bioscience (Landmark edition), 2017, 06-01, Volume: 22, Issue:10 Topics: Animals; Antigens, CD19; Cell Line, Tumor; Cells, Cultured; Cytokines; Cytotoxicity, Immunologic; HeLa Cells; Hematologic Neoplasms; Humans; Interleukin Receptor Common gamma Subunit; Male; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasms; Oligopeptides; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; T-Lymphocytes; Treatment Outcome; Xenograft Model Antitumor Assays	2017

Article

Year

FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells

Frontiers in bioscience (Landmark edition), 2017, 06-01, Volume: 22, Issue:10

Topics: Animals; Antigens, CD19; Cell Line, Tumor; Cells, Cultured; Cytokines; Cytotoxicity, Immunologic; HeLa Cells; Hematologic Neoplasms; Humans; Interleukin Receptor Common gamma Subunit; Male; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasms; Oligopeptides; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; T-Lymphocytes; Treatment Outcome; Xenograft Model Antitumor Assays

2017